Cardiogenic shock is a critical condition characterized by the heart’s inability to pump sufficient blood to meet the body’s needs, leading to inadequate tissue perfusion and oxygenation. This article provides an overview of the epidemiology, etiology, pathogenesis, pathophysiology, clinical features, differential diagnosis, diagnosis, and treatment of cardiogenic shock in infants and children, tailored for pediatric residents.
Epidemiology
Cardiogenic shock is less common in children compared to adults but remains a significant cause of morbidity and mortality in pediatric patients. It can occur at any age, from neonates to adolescents, with varying incidence based on underlying cardiac conditions and other risk factors. Congenital heart disease is a leading cause of cardiogenic shock in infants, while myocarditis and cardiomyopathies are more common in older children.
Etiology
The causes of cardiogenic shock in children can be broadly categorized into:
- Structural defects:
- Hypoplastic left heart syndrome.
- Severe coarctation of the aorta.
- Critical aortic stenosis.
- Transposition of the great arteries.
- Postoperative complications following cardiac surgery.
- Myocarditis:
- Viral.
- Bacterial.
- Autoimmune.
- Cardiomyopathies:
- Dilated.
- Hypertrophic.
- Restrictive.
- Arrhythmias:
- Supraventricular tachycardia.
- Ventricular tachycardia.
- Severe sepsis or septic shock leading to myocardial dysfunction.
- Drug toxicity:
- Chemotherapy agents.
- Beta-blockers.
- Metabolic disorders:
- Hypocalcemia.
- Hyperkalemia.
Pathogenesis and pathophysiology
The pathogenesis of cardiogenic shock involves a critical reduction in cardiac output due to impaired myocardial function. Recall that cardiac output is calculated as
(stroke volume x heart rate). Key mechanisms include:
This is the most common cause of cardiogenic shock, which leads to decreased stroke volumes and systolic dysfunction.
- Myocardial ischemia or infarction.
- Inflammatory damage (e.g., myocarditis).
- Cardiomyopathies.
- Systemic hypertension.
- Outflow tract obstruction (e.g., aortic stenosis).
- Hypovolemia
- Venous return obstruction: this is diastolic dysfunction that is caused by decreased myocardial compliance and thus inadequate filling during diastole, which then leads to decreased stroke volume during systole.
- Tamponade.
- Restrictive cardiomyopathy.
- Post-op tetralogy patients.
- Tachyarrhythmias reduce diastolic filling time in the acute setting, but then also long term causing systolic dysfunction due to excessive myocardial oxygen demand.
- Bradyarrhythmias reduce heart rate and thus cardiac output.
Clinical features
The clinical presentation of cardiogenic shock varies with age and underlying cause but commonly includes:
- Tachycardia.
- Hypotension.
- Cool, mottled extremities.
- Delayed capillary refill.
- Tachypnea.
- Hepatomegaly.
- Jugular venous distension.
- Pulmonary edema (e.g., crackles on auscultation).
- Altered mental status.
- Irritability.
- Lethargy.
- Seizures in severe cases
Differential diagnosis
Differential diagnosis involves distinguishing cardiogenic shock from other types of shock and conditions with similar presentations:
- History of fluid loss:
- Vomiting.
- Diarrhea.
- Hemorrhage (e.g., trauma, hematemesis).
- Signs of dehydration:
- Dry mucous membranes.
- Sunken eyes.
- Septic shock:
- Fever.
- Signs of infection.
- Bounding pulses.
- Brisk capillary refill.
- Anaphylactic shock:
- History of allergen exposure.
- Urticaria.
- Respiratory distress.
- Vomiting.
- Skin findings.
- Angioedema.
- Adrenal crisis:
- Chronic steroid use.
- History of adrenal insufficiency.
- Lack of response to inotropes.
- Tension pneumothorax:
- Absent breath sounds.
- Tracheal deviation.
- Cardiac tamponade:
- Muffled heart sounds.
- Pulsus paradoxus (larger than expected drop, >10, in systolic blood pressure during inhalation).
Diagnosis
Diagnosis of cardiogenic shock involves a combination of clinical assessment, laboratory tests, and imaging:
- Detailed history and physical examination.
- Assessment of vital signs, perfusion status, and mental state.
- Blood gas analysis to evaluate acid-base status.
- Lactate: At the cellular level the lack of oxygen to the cells leads to an interruption of oxidative phosphorylation that shifts the body into anaerobic metabolism, thus depleting ATP and increasing lactic acid production.
- Cardiac biomarkers:
- Troponin.
- BNP.
- Electrolytes and renal/liver function tests.
- Chest X-ray to assess heart size and for signs of pulmonary congestion.
- Echocardiography to evaluate cardiac function and for structural abnormalities.
- Electrocardiogram (ECG) to identify arrhythmias and ischemic changes.
Treatment
Treatment of cardiogenic shock focuses on improving cardiac output and addressing the underlying cause:
- Oxygen therapy to maintain adequate oxygenation.
- Mechanical ventilation for respiratory failure.
- Monitoring of vital signs, urine output, and laboratory parameters.
- Optimize preload: Using central venous pressures as an indicator of response, a fluid challenge can be done.
- If fluid is given and there is no change to the central venous pressure (meaning the heart tolerated the extra volume well), but there was a decrease to heart rate, improvement to perfusion, and increase to urine output, then further fluid can be given,
- If fluid is given and the central venous pressure increases or heart rate increases, that is concerning that the heart is not tolerating the volume well and the patient is at higher risk for pulmonary edema. In these cases, gentle diuresis should be attempted instead while balancing the patient’s total body fluid status and blood pressure.
- Inotropic agents (e.g., dopamine, dobutamine) to enhance myocardial contractility.
- Vasopressors (e.g., norepinephrine) for persistent hypotension and to improve contractility.
- Milrinone can improve contractility but also optimize afterload by reducing systemic vascular resistance.
- Diuretics (e.g., furosemide) for pulmonary congestion.
- High dose NSAIDs, steroids, or immunosuppressants for myocarditis.
- Antiarrhythmic drugs or electrical cardioversion for arrhythmias.
- Surgical intervention for structural heart defects.
- Extracorporeal membrane oxygenation (ECMO) for refractory cases.
- Ventricular assist devices (VADs) as a bridge to recovery or transplantation.
Conclusion
Cardiogenic shock in infants and children is a life-threatening condition that requires prompt recognition and aggressive management. Understanding the epidemiology, etiology, pathogenesis, pathophysiology, clinical features, differential diagnosis, diagnosis, and treatment is essential for pediatric residents to provide optimal care. Early intervention can significantly improve outcomes and reduce the risk of complications.
Image credits
Unless otherwise noted, images are from Adobe Stock.